Xeris Biopharma Holdings Inc (XERS)

Gross Margin

83.34%

TTM · Period ending:

XERS logo

XERS Gross Margin

Latest reported83.34%
XERS Gross Margin (99.26% → 83.34%)
High-resolution chart · PNG

XERS gross margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Gross Margin — Annual fiscal periods
Period endingGross Margin
81.6985%
81.8624%
82.5244%
79.4699%
73.1438%
54.3528%
41.1095%
98.2961%
99.7429%
99.2558%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.